Latest News about Briefs
Recent news which mentions Briefs
Ophthalmic Biopharmaceutical Ocuphire Pharma Shifts Focus To Gene Therapy Through Opus Genetics Stock Deal
October 23, 2024
From Benzinga
From Benzinga
Philip Morris' Q3 Driven By Smoke-Free Products Amid Rising Market Share In Key Regions: Analyst Forecasts Growth Across IQOS And ZYN Brands
October 23, 2024
From Benzinga
Verizon's 5G Expansion And Fiber Goals Boost Long-Term Outlook, Analysts Cautiously Optimistic
October 23, 2024
From Benzinga
Eli Lilly Alzheimer's Drug Faces Tough Road In UK, Price Watchdog NICE Says Donanemab Is Not Cost-Effective
October 23, 2024
Tickers
LLY
From Benzinga
PayPal Expands Partnership With Global Payments, Fastlane Checkout To Boost E-Commerce
October 23, 2024
From Benzinga
Norfolk Southern's Q3 Beat Fuels Analyst Optimism Despite Q4 Challenges—Long-Term Growth Potential In Focus
October 23, 2024
From Benzinga
Penny Stock DBV Technologies Advances Viaskin Peanut Allergy Patch With FDA Approval Pathway
October 23, 2024
From Benzinga
Block To See Improved Profitability Amid Expense Discipline In Q3: Analyst Forecasts Stable Payment Volume Growth
October 23, 2024
From Benzinga
AdTech Stock Magnite Gains as Disney Renews Key Deal, Expands ESPN and Podcast Offerings
October 23, 2024
From Benzinga
3M's Earnings Impress, Yet Analysts See Long Road Ahead With Cyclical Recovery And PFAS Risks
October 23, 2024
From Benzinga
Neuropsychiatry-Focused Alto Neuroscience's Mid-Stage Depression Trial Disappoints, Analyst Notes Failure Raises Concerns About Platform
October 23, 2024
From Benzinga
Shell Fuels The Future: New Deal with Ferrari And Power Plant Acquisition On The Horizon
October 23, 2024
From Benzinga
From Benzinga
General Motors Growth Potential In Focus Amid EV Transition: Analyst Highlights Robust Liquidity, More Buybacks
October 23, 2024
From Benzinga
From Benzinga
What's Going On With Nvidia Stock On Wednesday?
October 23, 2024
From Benzinga
Avery Dennison's Mixed Q3: Earnings Beat, Revenue Falls Short, Tightens Annual Outlook & More
October 23, 2024
From Benzinga
FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
October 23, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Seagate Technology Falls Despite Q1 Earnings Beat And Rising Margins
October 23, 2024
From Benzinga
Roper Tech Q3 Earnings: 13% Revenue Growth, Higher Cash Flow, Lifts Full-Year Outlook
October 23, 2024
From Benzinga
Amphenol CEO Credits 26% Sales Boost To IT, Mobile Networks, Acquisitions: 'We Again Realized Strong Profitability'
October 23, 2024
From Benzinga
Why Is Evotec Stock Gaining Today?
October 23, 2024
From Benzinga
Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual Forecast On Strong Demand For Heart Devices
October 23, 2024
From Benzinga
General Dynamics Delivers Mixed Q3 Performance, Aerospace And Marine Systems Lead Revenue Gains
October 23, 2024
From Benzinga
Thermo Fisher Scientific Sails Through Q3 With Mixed Earnings, CEO Says In Great Position To Deliver 2024 Objectives
October 23, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.